Randomized Phase II Study of BSC vs Cetuximab vs Irinotecan and Cetuximab in Patients with KRAS codon G13D mutant Metastatic Colorectal Cancer (G13 study)

Name: Randomized Phase II Study of BSC vs Cetuximab vs Irinotecan and Cetuximab in Patients with KRAS codon G13D mutant Metastatic Colorectal Cancer (G13 study)
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-03-07 收录

下载链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2624252

下载链接

链接失效反馈

官方服务：

资源简介：

Interventions: Cetuximab Cetuximab+Irinotecan BSC Primary outcome(s): Progression Free Survival Study Design: Parallel Randomized

创建时间：

2012-06-15